Form 4 for BNGO Bionano Genomics, Inc.
Accepted 2023-09-20 00:00:00 ET · period of report 2023-09-18 · accession 0001209191-23-050186 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-09-20 | 2023-09-18 | BNGO | OLDAKOWSKI MARK | COO | A - Grant | $0.00 | +20.0K | 317.8K | +7% | $0 |
| D | 2023-09-20 | 2023-09-18 | BNGO | OLDAKOWSKI MARK | COO | A - Grant | $0.00 | +40.0K | 40.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-18 | A | A | 20,000 | $0.00 | 317,842 | D | — | — | (F1) Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan. |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-09-18 | A | A | 40,000 | $0.00 | 40,000 | D | $3.00 · — to 2033-09-17 | 40,000 Common Stock | (F2) The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of September 11, 2023 (the "Vesting Commencement Date") such that the option shall be fully vested and exercisable on the four-year anniversary of the Vesting Commencement Date. |